Huons Global Co. Ltd (084110) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Huons Global Co. Ltd (084110) has a cash flow conversion efficiency ratio of 0.027x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩30.10 Billion ≈ $20.40 Million USD) by net assets (₩1.10 Trillion ≈ $742.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Huons Global Co. Ltd to measure how much of total assets are equity-financed.
Huons Global Co. Ltd - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Huons Global Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Huons Global Co. Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Huons Global Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Huons Global Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Twelve Seas Investment Co II
NASDAQ:TWLV
|
-0.001x |
|
Critical Holdings Berhad
KLSE:0291
|
-0.070x |
|
Karyopharm Therapeutics Inc
NASDAQ:KPTI
|
0.040x |
|
MIRC Electronics Limited
NSE:MIRCELECTR
|
-0.387x |
|
Compania Espanola de Viviendas en Alquiler SA
MC:CEV
|
0.006x |
|
JIUMAOJIU INTL HLDGS LTD
F:3YU
|
N/A |
|
Taylor Devices Inc
NASDAQ:TAYD
|
0.013x |
|
Summit Securities Limited
NSE:SUMMITSEC
|
0.011x |
Annual Cash Flow Conversion Efficiency for Huons Global Co. Ltd (2010–2025)
The table below shows the annual cash flow conversion efficiency of Huons Global Co. Ltd from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Huons Global Co. Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩1.09 Trillion ≈ $739.51 Million |
₩93.61 Billion ≈ $63.44 Million |
0.086x | -55.64% |
| 2024-12-31 | ₩520.11 Billion ≈ $352.47 Million |
₩100.57 Billion ≈ $68.16 Million |
0.193x | +76.15% |
| 2023-12-31 | ₩910.68 Billion ≈ $617.15 Million |
₩99.97 Billion ≈ $67.75 Million |
0.110x | -19.15% |
| 2022-12-31 | ₩464.32 Billion ≈ $314.66 Million |
₩63.04 Billion ≈ $42.72 Million |
0.136x | +46.56% |
| 2021-12-31 | ₩537.84 Billion ≈ $364.49 Million |
₩49.82 Billion ≈ $33.76 Million |
0.093x | -57.79% |
| 2020-12-31 | ₩412.83 Billion ≈ $279.77 Million |
₩90.59 Billion ≈ $61.39 Million |
0.219x | +26.73% |
| 2019-12-31 | ₩378.53 Billion ≈ $256.52 Million |
₩65.55 Billion ≈ $44.42 Million |
0.173x | +17.42% |
| 2018-12-31 | ₩362.21 Billion ≈ $245.47 Million |
₩53.42 Billion ≈ $36.20 Million |
0.147x | +5.87% |
| 2017-12-31 | ₩341.14 Billion ≈ $231.19 Million |
₩47.52 Billion ≈ $32.20 Million |
0.139x | +129.81% |
| 2016-12-31 | ₩319.80 Billion ≈ $216.72 Million |
₩19.38 Billion ≈ $13.14 Million |
0.061x | -79.89% |
| 2015-12-31 | ₩168.94 Billion ≈ $114.49 Million |
₩50.91 Billion ≈ $34.50 Million |
0.301x | +97.16% |
| 2014-12-31 | ₩188.38 Billion ≈ $127.66 Million |
₩28.79 Billion ≈ $19.51 Million |
0.153x | -22.72% |
| 2013-12-31 | ₩125.24 Billion ≈ $84.87 Million |
₩24.77 Billion ≈ $16.79 Million |
0.198x | +2.71% |
| 2012-12-31 | ₩92.92 Billion ≈ $62.97 Million |
₩17.89 Billion ≈ $12.13 Million |
0.193x | +125.39% |
| 2010-12-31 | ₩78.18 Billion ≈ $52.98 Million |
₩6.68 Billion ≈ $4.53 Million |
0.085x | -- |
About Huons Global Co. Ltd
Huons Global Co., Ltd. provides medical solutions for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and inj… Read more